Although a number of repair strategies have been shown to promote axon outgrowth following neuronal injury in the mammalian CNS, it remains unclear whether regenerated axons establish functional synapses and support behavior. Here, in both juvenile and adult mice, we show that either PTEN and SOCS3 co-deletion, or co-overexpression of osteopontin (OPN)/insulin-like growth factor 1 (IGF1)/ ciliary neurotrophic factor (CNTF), induces regrowth of retinal axons and formation of functional synapses in the superior colliculus (SC) but not significant recovery of visual function. Further analyses suggest that regenerated axons fail to conduct action potentials from the eye to the SC due to lack of myelination. Consistent with this idea, administration of voltage-gated potassium channel blockers restores conduction and results in increased visual acuity. Thus, enhancing both regeneration and conduction effectively improves function after retinal axon injury.
In Brief
Regenerated retinal axons can form functional synapses but exhibit poor conduction and thus fail to mediate functional recovery. Treatment with voltage-gated potassium channel blockers enhances conduction of regenerated axons and results in significant recovery of visual acuity.
INTRODUCTION
During neural development, a series of complex processes transform initial patterns of neuronal connectivity into optimized functional circuits that underlie behavior. As axons reach their targets, they form weak synapses that subsequently undergo both activity-independent and experience-dependent maturation and refinement (Hensch, 2005; Hong and Chen, 2011; Ackman and Crair, 2014) . Moreover, formation of myelin sheaths around axons enhances the speed and reliability of neural transmission. Progressive myelination during early postnatal and adolescent life allows fast and reliable propagation of neuronal activity along axons as the nervous system increases in size. However, it remains unknown whether a similar multi-step process of functional circuit regeneration can occur following axon injury in adulthood.
In cases of injury to the CNS such as traumatic brain injury and spinal cord injury, a key pathological event is the severing of long-projection axons, leading to the disruptions of relevant circuits (Case and Tessier-Lavigne, 2005; Blesch and Tuszynski, 2009; Fawcett et al., 2012; Lu et al., 2014) . Therefore, an ideal repair strategy would be to first promote regeneration of injured axons, followed by formation of new synapses with the disconnected target, and finally, optimization for proper functionality and reliability of the rebuilt circuits. Such restoration of function is robust following injury to sensory or motor axons in the mammalian peripheral nervous system, but is problematic in the CNS.
Based on recent findings in understanding the molecular and cellular mechanisms underlying regeneration failure, a number of strategies have been developed to enhance axon regeneration in the adult CNS. For example, neutralization or removal of growth inhibitory activities has been shown to enhance the regrowth of limited types of CNS axons with significant functional outcomes (Yiu and He, 2006; Lee and Zheng, 2008; Chew et al., 2012; Cregg et al., 2014; Schwab and Strittmatter, 2014; Silver et al., 2015) . In addition, regeneration can be enhanced by manipulating regulators of signaling pathways related to neuronal growth, such as PTEN/mTOR and SOCS3/ STAT3 (Park et al., 2008; Smith et al., 2009; Liu et al., 2010; Belin et al., 2015) , as well as development-associated transcription factors such as Krü ppel-like family of transcription factors (Moore et al., 2009; Blackmore et al., 2012) . For example, we found that genetic deletion of both PTEN and SOCS3 greatly invigorates the intrinsic regenerative ability of injured retinal ganglion cells (RGCs), resulting in robust long-distance axon regeneration in an intraorbital optic nerve injury model (Sun et al., 2011) . Furthermore, our recent studies showed that overexpression of an extracellular protein osteopontin (OPN) in RGCs allowed them to regenerate their injured axons in the presence of IGF1 or brain-derived neurotrophic factor (BDNF), pointing to a potentially translatable approach of activating neuronal mTOR pathway and promoting axon regeneration (Duan et al., 2015) .
It remains unclear, however, the extent to which axons induced to regenerate can form functional synapses with their presumptive targets in an adult neural network. To address this issue, we used an optic tract transection model that minimizes the distance axons need to regenerate to their targets. We were therefore able to systematically test post-regeneration steps that are critical for restoration of visual function. We discovered that regenerating axons indeed form functional synapses but exhibit poor conduction likely associated with lack of myelination. Strikingly, we showed that improving axon conduction by pharmacological means could lead to significant visual function recovery when combined with substantial axon regeneration.
RESULTS

Retinocollicular Axon Regeneration Induced by
Co-deletion of PTEN and SOCS3 in a Unilateral Optic Tract Transection Model RGC axons regeneration after intraorbital optic nerve crush need to grow for a long distance before reaching their CNS targets. With manipulations such as PTEN and SOCS3 co-deletion that have been effective in promoting regeneration, only a small number of regenerating axons cross the optic chiasm and even fewer reach their targets (Sun et al., 2011; Luo et al., 2013) . To examine post-regeneration events, we therefore adopted an optic tract injury model (So et al., 1981; Chen et al., 1997) , in which the optic tract is transected unilaterally just proximal to the SC in postnatal day 6 (P6) mice ( Figures 1A, 1B , and S1). This significantly reduces the distance regenerating axons must travel to reach their target. We used mice at P6 because the SC is not yet covered by the cortex at this age, rendering the optic tract accessible for surgery.
Immediately after optic tract transection, BCL-2 + /PTEN f/f / SOCS3 f/f mice were subjected to intravitreous injection of either AAV-Cre virus to delete PTEN and SOCS3 genes in the regeneration group or AAV-PLAP (placental alkaline phosphatase) virus in the control group ( Figure 1C ). The BCL-2 transgenic background was chosen for its documented effects on enhancing neuronal survival following injury (Bonfanti et al., 1996; Goldberg et al., 2002) , while genetic deletion in RGCs of PTEN and SOCS3, the respective inhibitory molecules of mTOR and JAK/STAT, for the robust axon regeneration in an optic nerve injury model (Sun et al., 2011) . To further boost the JAK/STAT activity after SOCS3 deletion (Smith et al., 2009; Sun et al., 2011) , we also injected AAVs expressing CNTF intravitreously 1 week after injury. Concurrently, we co-injected AAVs expressing a fusion of channelrhodopsin 2 and mCherry (ChR2-mCherry) so we could visualize RGC axons and activate them with light. We first confirmed that our surgical paradigm completely transected all retinocollicular axons in wild-type mice (Figures S1A and S1B). Axon regeneration was assessed by two independent axonal labeling methods (CTB in Figures 1D-1L or mCherry in Figure 1M ). In the control group (BCL-2
with AAV-PLAP), we found little axon labeling in the SC caudal to the lesion site ( Figures 1D-1G , 1L, and 1M). Analysis of serial sections throughout the entire SC revealed that many axons retracted and failed to regenerate ( Figure S2A ). Figures 2C and 2F , n = 7 out of 7, mean amplitude: 529 ± 22 mV). In contrast, we were able to record reliable light-evoked responses in the post-lesion SC of seven out of eight mice in the regeneration group ( Figures 2E, 2F , and S3B, mean amplitude: 136 ± 41 mV). To distinguish the contribution of synaptic from non-synaptic components, we applied the glutamate receptor antagonist kynurenic acid (50 mM) locally to the exposed SC and found that the drug administration acutely and reversibly diminished the amplitude of the evoked LFP (Figures 2G and 2H) . Thus regenerated axons formed functional synapses in the SC.
Reformation of Functional Synapses Detected by Whole-Cell Recording
To probe the nature of the regenerated synapses, we performed whole-cell intracellular recording from SC brain slices 4-5 weeks after injury ( Figure 2I ). Consistent with in vivo recordings, lightevoked postsynaptic responses were detected in SC neurons located over 300 mm distal to the lesion in regeneration-group mice (n = 12/12 cells across four mice, Figure 2J ) but not in control-injured mice (n = 0/10 cells across four mice). In this recording protocol, membrane potential was first held at À70 mV with magnesium in the solution to block NMDA receptors, allowing AMPA receptor-mediated synaptic currents to be recorded (Hooks and Chen, 2006; Shah and Crair, 2008 ). The membrane potential was then switched to +55 mV to remove magnesium blockade, and combined currents mediated by AMPA and NMDA receptors were revealed. As expected, light-evoked AMPA responses were blocked by the AMPA receptor antagonist CNQX (10 mM; by 100% of baseline in four mice) and the NMDA responses blocked by addition of the NMDA receptor antagonist D-APV (50 mM; by 77% of baseline in four mice) ( Figures 2K and 2L) . Together, these results (legend continued on next page) demonstrate that regenerated axons activate both AMPA and NMDA glutamatergic receptors in the SC.
Failed Behavioral Recovery Induced by Regenerated Axons
To ask whether the regenerated synapses in the SC were sufficient to mediate visual behavior, we assayed optomotor function in freely behaving animals eight weeks after injury. In this assay ( Figure 3A ), a mouse is placed on a platform surrounded by four monitors that show a moving contrast reversal (Prusky et al., 2004) . The mouse optomotor response, defined by the move- ment of the head tracking the moving screen, entails proper function of subcortical nuclei including SC (Huberman and Niell, 2011) . The acuity of each eye can be measured independently as the maximal spatial frequency at which the head is able to track the stimulus (Prusky et al., 2004; Kang et al., 2013) . Mice were tested blindly with respect to both genotype and treatment. As expected, mice in the control group exhibited a profound performance defect in the injured but not in the intact eye ( Figures 3B, 4G, and 4H) . Surprisingly, the regeneration group mice also exhibited poor optomotor acuity; no response was observed in six of eight animals and the group score was not significantly different from that of injured control mice ( Figure 3B ).
Conduction Blockade in Regenerated Axons
We next asked whether the lack of visual behavior in regeneration-group mice was associated with the failure of action potentials generated in RGCs to reach the targets. To address this question, we again performed LFP recordings in vivo. Holding the recording electrode at a single site in the SC, we re-positioned the stimulating optical fiber in front of the eye after recording LFPs evoked by stimulating terminals within the SC ( Figure 3C ). Robust eye-evoked LFPs were recorded from sham-operated mice and their amplitudes were comparable to those of the terminal-evoked LFPs (Figures 2C and 3D ). As Figure S4 for all regeneration-group mice in (G) and (I).
expected, no eye-evoked LFPs were detected in the control mice (Figures 3E and 3G versus 2D and 2F) . Interestingly, in regeneration-group mice, eye stimulation elicited only a small LFP from SC ( Figures 3F and 3G ): the maximal amplitudes of the eye-evoked LFP was only 14% of the terminal-evoked LFP ( Figure 3H ), and the ratio was similar after a further 6-8 weeks-that is, 14-16 weeks after injury (data not shown). Thus although functional synapses reform after optic tract injury, conduction is impaired in the regenerated axons.
Lack of Myelination in Regenerated Axons
Myelination is required for efficient electrical conduction by axons of many long-projection neurons, including those of RGCs. Conflicting results have been reported on myelination of regenerated axons in the adult CNS (Alto et al., 2009; de Lima et al., 2012) . We therefore assessed myelination of regenerated retinocollicular axons in our preparation by labeling SC sections with antibodies to mCherry (labeling ChR2-mCherry-labeled regenerating axons) and myelin-associated glycoprotein (MAG, a marker of myelination). We readily visualized myelinated axons in sham controls, but detected no MAG co-localized with ChR2 in and across the lesion site ( Figures 3I and 3J ), indicating that regenerated axons were poorly myelinated. A myelination deficit would expose potassium channels that are otherwise located under the myelin sheath, resulting in radial dispersion of action potential driven current into the extracellular space, effectively ''short-circuiting'' the action potential (Waxman and Ritchie, 1993) . Consistent with this idea, we found that inducing focal demyelination in the optic tract by a well-established method-i.e., local application of lysolecithin (Woodruff and Franklin, 1999) (Figures S4A and  S4B )-compromised conduction of retinocollicular axons and diminished optomotor performance ( Figures S4C-S4E ).
4-AP Enhances Eye-Evoked Responses and Optomotor Performance
The voltage-gated potassium channel blocker 4-aminopyridine (4-AP) (Bostock et al., 1981) significantly improves conduction in de-myelinated axons of patients with multiple sclerosis (Smith et al., 2000; Hayes, 2004) . Consistently, 4-AP improved the function of lysolecithin-demyelinated RGC axons ( Figures S4C-S4E ). We therefore asked whether 4AP could enhance eye-evoked LFPs in our regeneration model. Remarkably, acute application of 4-AP to the exposed SC enhanced the amplitude of LFP response evoked from the eye by an average of 55%, but had no significant effects on the terminal-evoked LFPs (Figures 4A-4C ). Application of vehicle control had no effect on either eyeor terminal-evoked LFPs ( Figures 4D-4F ). Thus, 4-AP improves conduction of regenerating axons. Next, we evaluated whether 4-AP treatment could ameliorate the behavioral visual defect. Control and regeneration-group mice were tested in the optomotor task before and 3 hr after systemic (intraperitoneal, I.P.) administration of 4-AP (4 mg/kg). The optomotor acuity of the injured eye was significantly improved in six of eight regeneration-group mice tested ( Figures 4G and 4I) . The effect of 4-AP was transient, as optomotor acuity returned to baseline by 6 hr after 4-AP administration. Administration of 4-AP had no significantly effect on acuity in control mice (Figure 4H ). In agreement with the behavioral results, subsequent histological analysis confirmed that six of eight mice in the regeneration group but no control mice showed successful axon regeneration and few regenerated axons were seen in the SC of the two regeneration-group mice that were non-responsive to 4-AP treatments ( Figures 4G, 4I, and S4F) . Thus, axon regeneration combined with acute 4-AP treatment enables significant behavioral recovery.
Behavioral Recovery after Optic Tract Transection in Adult Mice
In experiments presented above, the optic tract was transected at P6. To test whether our strategies could also improve function after injury performed in the adults, we modified our optic tract injury model. We first aspirated part of the cortex, exposing the optic tract entering the right SC, and then transected the entire optic tract. As a result, this surgical procedure led to complete loss of retinal inputs to the SC as well as the pretectal nuclei and a profound defect in optomotor performance ( Figures S5A and S5B ).
We performed this optic tract transection in adult PTEN
f/f mice that had received intravitreous injection of AAVsCre/CNTF (or AAV-PLAP) at the age of 8 weeks ( Figure 5A ). Different from neonatal injury, the majority of injured RGCs survive after adult optic tract injury, so we did not use the BCL-2 transgenic background in these studies. A second intravitreous injection of AAV-ChR2-mCherry was performed 1 week after the optic tract transection. Recovery was assessed $3 months later by behavioral, physiological, and histological criteria. As in the juvenile injury model, the combination of intravitreous AAVsCre/CNTF treatment and acute 4-AP administration (4 mg/kg, I.P.) significantly improved the optomotor acuity of the injured adult eye without affecting performance of the intact eye ( Figures  5B-5D and S5C ). Using in vivo extracellular recording, we found modest eye-evoked LFPs in SC that were significantly increased after acute 4-AP treatment ( Figures 5E-5I and S5C) .
Histological examination revealed regenerated ChR2-mCherrylabeled axons crossing the lesion and projecting into the SC only in the mice treated with AAVs-Cre/CNTF but not with AAV-PLAP ( Figures 6A-6H ). Some regenerating axons also projected aberrantly along the lesion site toward the ventral brain area and in a few cases, others formed vertical columns in the distal SC (Figure 6G) , reminiscent of the termination pattern reported by Cang and Feldheim (2013) . Importantly, there was a correlation between the extent of axon regeneration and the electrophysiological and behavioral outcomes in individual animals of the AAVs-Cre/ CNTF-treated group ( Figure S5C ). Finally, using anti-MAG immunostaining, we again failed to find any evidence of myelination at and distal to the lesion site ( Figures 6I and 6J) . Together, these data indicate that even following adult injury, PTEN and SOCS3 deletion followed by 4-AP treatment led to significant restoration of visual function.
Functional Improvements Induced by Post-injury Treatments Since in humans, treatments would need to be administered after injury, we asked whether deleting PTEN/SOCS3 after injury improved visual function. We performed optic tract transection in adult PTEN ( Figure S6A ). The mice were analyzed behaviorally, physiologically, and histologically 15-16 weeks after injury. Regeneration of retinocollicular axons occurred after this delayed treatment and mice exhibited significant improvement in optomotor performance if 4-AP was administered before testing ( Figures  S6B-S6G ).
Another important issue in this protocol is that the achievable concentration of 4-AP in vivo is two orders of magnitude below its maximal effective dosage seen in vitro, due to severe side effects seen in higher concentrations (Blight et al., 1991; Donovan et al., 2000) . Recently, the 4-AP derivative, 4-aminopyridine-3-methanol (4-AP-3-Me), was found to have higher potency and ) showing only the ChR2 staining. There were significant differences between control and regeneration groups at every distance from 0 to 0.5 mm distal to the lesion (p < 0.05, ANOVA with Bonferroni post-test). Scale bars, 300 mm (A and G); 50 mm (E).
(I and J) ChR2-mCherry-positive regenerated axons are not co-localized with anti-MAG immunoreactivity signal in the adult-injured mice (I) and quantification (J) showing that $80% of the ChR2-mCherry-labeled axonal segments in the sham-operated mice (272 out of 336 across three mice), but none of regenerated axonal segments (0 out of 330 across three mice) were co-localized with MAG. Scale bars, 10 mm and 1 mm (inset). N/A, not applicable. Data are represented as mean ± SEM. Histological analysis was performed in the mice that had previously undergone functional tests. (legend continued on next page) possible lower side effect of impacting electrophysiological properties (Sun et al., 2010) . We found that 4-AP-3-Me, even at a lower dosage, improved optomotor performance and increased electrophysiological conduction of regenerated axons ( Figures S6C-S6E ) in mice with delayed deletion of PTEN and SOCS3. Thus, our results suggested that this 4-AP-3-Me might have a better safety margin than 4-AP for in vivo applications.
Functional Improvement Induced by Combined Administration of OPN, IGF1, CNTF, and 4-AP Downregulation of PTEN and SOCS3 could have harmful effects that would limit their use in enhancing regeneration. In light of our recent finding that overexpression of the extracellular protein osteopontin (OPN) and IGF1 or BDNF promotes optic nerve regeneration (Duan et al., 2015) , we tested whether this potentially more translatable approach could also mediate functional recovery. To maximize the number of regenerating axons, we first analyzed the axon regeneration outcomes after AAV-assisted combinatorial expression of OPN/IGF1 and CNTF in adult RGCs after optic nerve injury. As shown in Figures S7A and S7D, this treatment indeed resulted in significant optic axon regeneration that was comparable to that seen after PTEN/ SOCS3 deletion plus CNTF treatment after optic nerve injury ( Figure S7B ). We then examined whether OPN/IGF1/CNTF triple treatment, applied after injury, could promote retinocollicular axon regeneration and mediate functional recovery in a more challenging version of the optic tract crush model ( Figure 7A ). We injured the optic tract at its most anterior part, $2 mm proximal to the SC ( Figure 7E ). At 15-16 weeks post-injury, the mice in different groups were subjected to optomotor behavioral test, electrophysiological measurements, and histological analysis. As shown in Figure 7B , the mice with the OPN/ IGF1/CNTF but not vehicle treatment showed improved performance in the optomotor task only in the presence of AP or 4-AP-3-Me.
Consistent results were also observed for electrical conduction as measured by electrophysiological recording ( Figure 7C ). Furthermore, histological examination showed that the triple treatments led to robust regeneration of injured retinocollicular axons ( Figures 7D-7G ). While some sprouting axons were seen along the pathway, many regenerated axons grew more than 2 mm prior to entering the SC and then elaborated extensive sprouting within the SC (Figures 7E-7G) . Also similar to that seen with PTEN/SOCS3 deletion, no co-staining of ChR2 (labeling axons) and MAG (labeling myelin) was observed for the OPN/ IGF1/CNTF-induced regenerating axons ( Figure 7H ). Together, these results indicated that treatment with OPN/IGF1/CNTF and 4-AP or 4-AP-3-Me can restore visual function following axotomy in wild-type adult mice.
DISCUSSION
Myelination of Regenerated Axons and Functional Recovery
We showed here that regenerating RGC axons form functional synapses following transection in young and adult mice. However, these synapses fail to restore visual behavior. In analyzing this failure, we found a profound conduction blockade associated with the regenerated axons. Previous studies that induced axon regeneration by combinatorial treatment, including PTEN deletion, report conflicting results with respect to myelination and visual behavioral recovery (de Lima et al., 2012; Luo et al., 2013) . Thus, with our findings, as well as prior results showing that regenerated ascending axons from sensory neurons in the spinal cord are poorly myelinated (Alto et al., 2009) , we propose that the myelination is a limiting step toward functional recovery after axon regeneration.
The myelination of axons, particularly for long projection axons, is essential for relaying electrical signals and coordinating neurons in different locations. This is evident from cases of multiple sclerosis. For example, despite relative preservation of axons, many patients with optic neuritis show visual disturbances, likely due to inflammation-triggered demyelination (Toosy et al., 2014) . Lack of myelination is similarly disadvantageous for regenerating RGC axons, as they must conduct action potentials over long distances to retinorecipient areas.
However, it is also important to note that in the intact adult mice some types of axons are non-myelinated, such as the brainstem-derived serotonergic axons in the spinal cord. Indeed, neutralizing inhibitory activities in the environments after spinal cord injury have been shown to promote the regrowth of serotonergic axons with subsequent functional recovery (Alilain et al., 2011; Hellal et al., 2011; Lang et al., 2015; Ruschel et al., 2015) . Similarly, terminals of corticospinal tract (CST) axons are not myelinated (Zukor et al., 2013) , and stimulating sprouting of CST axons in the gray matter of the spinal cord leads to partial recovery of forelimb function (Cafferty and Strittmatter, 2006; García-Alías et al., 2009; Wahl et al., 2014) . In contrast, CST axons are myelinated along most of their length, and normally myelinated axons more likely need to acquire myelin following regeneration to allow efficient conduction and functional recovery.
It remains unclear why regenerated RGC axons fail to re-myelinate. This could be due to altered responses in regenerating axons and/or myelinating cells. Future studies are therefore needed to elucidate how oligodendrocyte precursors respond to injury and whether they can be induced to differentiate and form myelin around regenerated axons (Zuchero and Barres, 2013) . Recent studies demonstrating that active myelination is involved in motor skill learning (Gibson et al., 2014; McKenzie (D-G) Images and quantification of ChR2-labeled regenerated axons. No axon regenerated was observed in the mice treatment with PLAP (D and G); many axons seem to retract from the injury site. In contrast, OPN/IGF1/CNTF treatment resulted in long-distance axon regeneration up to 4 mm away from the injury site (E and G). Some axons sprouted along the pathway (E) and some elaborated extensively within the SC (F). Axons in boxed area in (E) is enlarged in (F). Scale bars, 300 mm (D); 50 mm (F). (H) Images showing that ChR2-mCherry-positive regenerated axons are not co-stained with anti-MAG immunoreactivity signal (labeling myelin). Over 200 individual axonal segments were examined and no co-staining was observed. Scale bars, 10 mm. See also Figures S5, S6 , and S7. et al., 2014), suggest modulating neuronal activity as a means of promoting myelination.
Visual Functional Recovery Mediated by Regenerated Axons
We showed that pharmacologically enhancing axonal conduction allows regenerated axons to mediate significant improvement in an optomotor behavioral task (Prusky et al., 2004) . Either an optic nerve crush or an optic tract transection abolish mice's performance in this assay, consistent with the notion that subcortical visual centers are critical for this performance (Masseck and Hoffmann, 2009; Huberman and Niell, 2011) . Because regenerating axons project not only to SC but also to pretectal nuclei, we do not know which targets mediate the observed behavioral recovery.
The incomplete functional recovery we observe might be due to the small number of regenerating axons or failure of regenerated axons to form topographically appropriate connections within their targets. Based on previous findings that task-specific training might facilitate the establishment of functional topographic mapping (Dunlop et al., 2007) , it will be interesting to test whether other accessory rehabilitative training might further enhance functional recovery.
In this regard, it is important to note that during normal development many synapses require both activity-dependent and -independent processes to mature (Hensch, 2005; Hong and Chen, 2011; Hooks and Chen, 2006; Shah and Crair, 2008; Ackman and Crair, 2014) . It remains to be tested whether RGC activity is required for the restoration of function during regeneration and whether additional activity might promote additional maturation.
Therapeutic Applications
The observed functional recovery in our models suggests that strategies for enhancing the intrinsic regenerative ability of injured axons are useful repair strategies. In addition to genetic approaches, AAV-assisted overexpression of OPN/IGF1/CNTF after injury promoted long-distance regeneration of retinal axons after both optic nerve and optic tract injury models. Because osteopontin might act as an extracellular cytokine (Kahles et al., 2014) , it is conceivable that a soluble form of osteopontin, together with a growth factor, might represent a therapeutic method of transiently activating regenerative ability in mature neurons.
Likewise, 4-AP, an FDA-approved potassium channel blocker, could represent a possibly translatable therapeutic paradigm to overcome the conduction blockade following damage or diseases. In this aspect, Grijalva et al. (2010) showed that a high dose of 4-AP treatment resulted in significant functional recovery in patients of chronic spinal cord injury with cord continuity at injury site. Although high doses of 4-AP lead to troubling side-effects (Hayes, 2004) , we show that its derivative 4-AP-3-Me mimics the effects of 4-AP at lower doses, suggesting an alternative treatment to 4-AP. An alternative approach would be to promote remyelination, for example by blocking activity of LINGO-1, a negative regulator of myelination (Mi et al., 2013) . This approach has proven useful in clinical trials for the patients with optic neuritis, a condition commonly associated with multiple sclerosis (http://clinicaltrials.gov). Together, these results encourage testing whether combining treatments for promoting axon regeneration and improving nerve conduction might be able to achieve functional recovery in clinical settings.
EXPERIMENTAL PROCEDURES
Young SC Injury Model After a bone flap, a lateral-to-medial cut applied to anesthetized P6 pups to transect the entire right SC. Then, AAV-Cre or AAV-PLAP was injected intravitreously into the left eyes of these pups. One week after SC injury, these mice received additional intravitreous injection of AAV-CNTF or AAV-PLAP (along with AAV-ChR2-mCherry in some experiments). In some experiments, cholera toxin beta subunit (CTB, 1 mg/ml, Invitrogen) was injected intravitreously to trace the retinocollicular axons.
Adult SC Injury Model
In anesthetized adult mice, a cranial window was created over the right cortex and cortical/hippocampal tissues were aspirated to reveal the right optic tract entering the right SC. The entire optic tract was then completely crushed by a pair of modified forceps. One or two weeks after injury, AAV-ChR2-mCherry was injected intravitreously into the left eyes for performing ChR2-based electrophysiology as well as axonal tracing.
LFP Recording In Vivo
After surgical exposure of the SC, a glass pipette recording electrode was then inserted vertically into the exposed SC at least 300 mm caudal to the lesion. To record terminal-evoked LFPs, an optical fiber with blue laser (470 nm) was used to illuminate the area with the same constant output. After the terminal-evoked LFP was recorded, the tip of the optic fiber was then repositioned to the eye to record the ''paired'' eye-evoked LFP.
Whole-Cell Intracellular Recording In Vitro
Parasagittal slices containing the SC were prepared, and recording was performed at room temperature. Picrotoxin (100 mM) was added to the recording solution to block GABA receptor-mediated responses. Whole-cell patch clamp recording of synaptic responses was made as described in Hooks and Chen (2006) .
Optomotor Test
Optomotor test was performed by an independent experimenter in a blinded fashion using a virtual optomotor system (CerebraMechanics). A rotating grating perceptible to the mouse was projected on a virtual cylinder wall, and the mouse was allowed to track the grating with reflexive head movements in concert with the rotation. The highest spatial frequency of the grating tracked in either direction was recorded as the eye's acuity. L.H., T.K.H., E.F., J.R.S., C.C., M.F., and Z.H. contributed equipment/materials and study design.
